Abbott Laboratories (NYSE:ABT) detailed fourth-quarter 2025 results and outlined its 2026 outlook on its earnings conference call, emphasizing continued momentum in medical devices, a transition plan ...
Piezofluorochromism, the phenomenon of materials reversibly changing their fluorescent color when pressure is applied, is ...
Despite guideline recommendations and improved access to care, individuals with hypertension are unlikely to measure their ...
Medtronic plc is rated a Buy with solid growth prospects, balance sheet remains A-rated and shares are undervalued. Learn ...
Exceeds guidance with 22% sales growth and over 30% EPS growth year over year GALWAY, Ireland, Jan. 21, 2026 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL) today reported results for the ...
Exceeds guidance with 22% sales growth and over 30% EPS growth year over yearGALWAY, Ireland, Jan. 21, 2026 /PRNewswire/ -- ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Predicted earnings growth for SDI as a group is modest, with 13.6 per cent penned in for the financial year ending in April ...
DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...
The S&P/ASX 200 is set to open higher as major US benchmarks continue to press all-time highs. Here are today's top stories.
Todd Ahlsten, chief investment officer with Parnassus Investments, says while the Mag 7 have driven much of the market, ...
The temperature is rising on NHL teams performing below expectations at the midway point of the season. We usually have at least one person on The Hockey News' Hot Seat Radar whose seat is "cooling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback